Trial NCT00089076

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02784
Secondary IDs: 6359 MC0312 NCI-2012-02784 P30CA015083 U01CA069912

Last trial update was posted on 2014-05-30

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Immunoglobulins Ipilimumab

MeSH Conditions

Burkitt Lymphoma Hodgkin Disease Intraocular Lymphoma Leukemia Leukemia, Hairy Cell Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Lymphoma, B-Cell Lymphoma, B-Cell, Marginal Zone Lymphoma, Extranodal NK-T-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Lymphoma, Large-Cell, Immunoblastic Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin Lymphomatoid Granulomatosis Plasmablastic Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Recurrence Waldenstrom Macroglobulinemia

Other Conditions

Adult Grade III Lymphomatoid Granulomatosis B-cell Chronic Lymphocytic Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Refractory Hairy Cell Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenström Macroglobulinemia

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID